Wolverine Asset Management
FLACW

Wolverine Asset Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Wolverine Asset Management’s Portfolio FLACW Stock Details FLACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,360
Closed -$2K – 2775
2022
Q2 		$2K Buy
+32,360
New +$5.62K ﹤0.01% 2267

Other funds holding FLACW

Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
Shaolin Capital Management
Shaolin Capital Management Miami, Florida $2.42B AUM 0.61% 1-Year Est. Return
MYDA Advisors
MYDA Advisors Woodmere, New York $900M AUM 46.04% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Arena Investors
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Wolverine Asset Management's FLACW Position: Q3 2022 in Review

Wolverine Asset Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 32,360 shares — an estimated $2K sold.

Wolverine Asset Management first reported a position in FLACW in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

  • Wolverine Asset Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 32,360 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $2K.
  • Wolverine Asset Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2022 and held it in 1 quarter.
  • Wolverine Asset Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $2K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.